Table 4.
Pre-octreotide (N = 63) | Post-octreotide (N = 18) | P value |
|
---|---|---|---|
Lesions identified as source of GI bleeding | |||
Arteriovenous malformation | 28 (44%) | 5 (28%) | 0.18 |
Erosion, gastritis or colitis | 8 (13%) | 1 (6%) | 0.48 |
Dieulafoy lesion | 2 (3%) | 0 (0%) | 0.42 |
Diverticulum | 1 (2%) | 0 (0%) | 0.75 |
No active site identified | 24 (38%) | 12 (67%) | 0.028* |
Localization of GI bleeding | |||
Esophagus | 2 (3%) | 0 (0%) | 0.42 |
Stomach/duodenum | 17 (27%) | 5 (28%) | 0.94 |
Small intestine | 12 (19%) | 0 (0%) | 0.042* |
Large intestine | 8 (13%) | 1 (6%) | 0.52 |
Unknown origin | 24 (38%) | 12 (67%) | 0.028* |
Performed therapy | |||
Clipping | 5 (8%) | 0 (0%) | 0.24 |
Argon plasma coagulation | 19 (30%) | 3 (17%) | 0.28 |
Infrared radiation embolization | 2 (3%) | 0 (0%) | 0.42 |
No invasive therapies | 37 (59%) | 15 (83%) | 0.044* |
p <0.05 by McNemar’s test